Our consolidated statements of income include sales to and purchases from unconsolidated affiliates in the ordinary course of business as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Sales to unconsolidated affiliates	$	7,214	$	4,998	$	14,869	$	10,728
Purchases from unconsolidated affiliates(a)	$	314,886	$	55,771	$	531,440	$	88,921

(a)Increases in purchases from unconsolidated affiliates primarily relate to increased pricing and volume of spodumene purchased from our Windfield joint venture.

Our consolidated balance sheets include accounts receivable due from and payable to unconsolidated affiliates in the ordinary course of business as follows (in thousands):


	June 30, 2022		December 31, 2021
Receivables from unconsolidated affiliates	$	3,091	$	2,139
Payables to unconsolidated affiliates(a)	$	204,209	$	47,499

(a)Increases in payables to unconsolidated affiliates primarily relate to increased purchases of spodumene purchased from our Windfield joint venture under normal payment terms.